# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA856191 | F | Compound was tested for in vitro growth inhibition of primary panel tumor cell line HT1376 | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
2. | ALA697634 | F | In vitro inhibitory activity against growth of Human bladder carcinoma (HT1376) cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
3. | ALA698279 | F | In vitro inhibitory activity against growth of Human bladder carcinoma (HT1376) cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
4. | ALA859903 | F | Cytotoxicity against human bladder carcinoma, HT1376 cells | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
5. | ALA2065302 | F | Cytotoxicity against human HT-1376 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
6. | ALA2363293 | F | SANGER: Inhibition of human HT-1376 cell growth in a cell viability assay. | Homo sapiens | 98 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
7. | ALA3877010 | F | Antiproliferative activity against human HT-1376 cells after 72 hrs by MTT assay | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
8. | ALA3883004 | F | Cytotoxicity against human HT-1376 cells after 3 days by InCell analyser assay | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data |